Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEOPROBE CORP | 78,000 | reported | 30 Jun 2017 | tx 3+128,000 |
| BRAINSTORM CELL THERAPEUTICS INC | 2,500 | reported | 15 Oct 2014 | tx 8+5,719,300 |
| EPICEPT CORP | 0 | reported | 03 Feb 2020 | tx 4+165,000−75,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2020 | SALE | EPICEPT CORP | 75,000 | 0.00 USD | |
| 22 May 2018 | PURCHASE | EPICEPT CORP | 25,000 | 0.24 USD | |
| 17 May 2018 | PURCHASE | EPICEPT CORP | 50,000 | 0.26 USD | first after silence |
| 14 Sept 2017 | GRANT_AWARD | EPICEPT CORP | 90,000 | 0.00 USD | deriv |
| 30 Jun 2017 | GRANT_AWARD | NEOPROBE CORP | 50,000 | 0.00 USD | |
| 30 Jun 2017 | GRANT_AWARD | NEOPROBE CORP | 50,000 | 0.00 USD | deriv |
| 20 Apr 2016 | GRANT_AWARD | NEOPROBE CORP | 28,000 | 0.00 USD | |
| 15 Oct 2014 | PURCHASE | BRAINSTORM CELL THERAPEUTICS INC | 300 | 3.60 USD | |
| 15 Oct 2014 | PURCHASE | BRAINSTORM CELL THERAPEUTICS INC | 200 | 3.59 USD | |
| 18 Sept 2014 | PURCHASE | BRAINSTORM CELL THERAPEUTICS INC | 800 | 3.84 USD | |
| 15 Sept 2014 | PURCHASE | BRAINSTORM CELL THERAPEUTICS INC | 3,000 | 0.28 USD | |
| 15 Sept 2014 | PURCHASE | BRAINSTORM CELL THERAPEUTICS INC | 5,000 | 0.29 USD | |
| 12 Sept 2014 | PURCHASE | BRAINSTORM CELL THERAPEUTICS INC | 7,500 | 0.29 USD | |
| 12 Sept 2014 | PURCHASE | BRAINSTORM CELL THERAPEUTICS INC | 2,500 | 0.28 USD | |
| 09 Jun 2014 | GRANT_AWARD | BRAINSTORM CELL THERAPEUTICS INC | 5,700,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 17 May 2018.